Phenotypic Evaluation of Nucleoside Analogues against <i>Trypanosoma cruzi</i> Infection: In Vitro and In Vivo Approaches
Chagas disease, caused by <i>Trypanosoma cruzi</i> (<i>T. cruzi</i>), is a serious public health problem. Current treatment is restricted to two drugs, benznidazole and nifurtimox, displaying serious efficacy and safety drawbacks. Nucleoside analogues represent a promising al...
Main Authors: | Ludmila F. de A. Fiuza, Denise G. J. Batista, Roberson D. Girão, Fabian Hulpia, Paula Finamore-Araújo, Mustafa M. Aldfer, Ehab Kotb Elmahallawy, Harry P. De Koning, Otacílio Moreira, Serge Van Calenbergh, Maria de Nazaré C. Soeiro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/22/8087 |
Similar Items
-
The <i>Trypanosoma cruzi</i> TcrNT2 Nucleoside Transporter Is a Conduit for the Uptake of 5-F-2′-Deoxyuridine and Tubercidin Analogues
by: Mustafa M. Aldfer, et al.
Published: (2022-11-01) -
Cloning and Characterization of <i>Trypanosoma congolense</i> and <i>T. vivax</i> Nucleoside Transporters Reveal the Potential of P1-Type Carriers for the Discovery of Broad-Spectrum Nucleoside-Based Therapeutics against Animal African Trypanosomiasis
by: Marzuq A. Ungogo, et al.
Published: (2023-02-01) -
Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors
by: Liudmila A. Alexandrova, et al.
Published: (2022-06-01) -
Nucleoside Transport and Nucleobase Uptake Null Mutants in <i>Leishmania mexicana</i> for the Routine Expression and Characterization of Purine and Pyrimidine Transporters
by: Mustafa M. Aldfer, et al.
Published: (2022-07-01) -
Nucleoside analogues for the treatment of animal trypanosomiasis
by: Dorien Mabille, et al.
Published: (2022-08-01)